Tumor infiltrating lymphocytes (TILs), the most widely studied populations of TIICs, are reported as important prognostic factor in HER2+ breast cancer and in TNBC, as their presence is associated with enhanced overall survival (OS) and better response to treatments [36]. This evidence concerns the gene ERBB2 and breast carcinoma.